Nuvalent DEF 14A: Executive Compensation Details
Ticker: NUVL · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1861560
Sentiment: neutral
Topics: executive-compensation, proxy-statement, board-members, equity-awards
Related Tickers: NUVAL
TL;DR
Nuvalent DEF 14A out: exec comp & equity awards detailed for board members like Porter, Noci, Miller.
AI Summary
Nuvalent, Inc. filed a DEF 14A on April 28, 2025, detailing executive compensation and board member information. Key individuals like Darlene Noci, Deborah Miller, Alexandra Balcom, and James R. Porter are listed with compensation-related dates in 2024 and 2023. The filing also includes information on equity awards granted and their fair value changes for executive and non-executive members.
Why It Matters
This filing provides transparency into how Nuvalent compensates its top executives and board members, which can influence investor decisions and perceptions of company governance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not contain new material financial information or strategic changes.
Key Players & Entities
- Nuvalent, Inc. (company) — Filer
- Darlene Noci (person) — Board Member
- Deborah Miller (person) — Board Member
- Alexandra Balcom (person) — Board Member
- James R. Porter (person) — Board Member
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When was this DEF 14A filing submitted by Nuvalent, Inc.?
Nuvalent, Inc. filed this DEF 14A on April 28, 2025.
Which individuals are specifically mentioned in relation to compensation or equity awards in this filing?
The filing mentions Darlene Noci, Deborah Miller, Alexandra Balcom, and James R. Porter in contexts related to compensation and equity awards, with specific dates in 2024 and 2023.
What type of compensation information is detailed in this filing?
The filing details information regarding equity awards, including changes in fair value of outstanding and unvested equity awards granted in prior years, and equity awards in summary compensation tables.
What is the fiscal year end for Nuvalent, Inc. as stated in the filing?
Nuvalent, Inc.'s fiscal year ends on December 31st.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 by Darlene Noci regarding Nuvalent, Inc. (NUVL).